People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Pharmaceuticals, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
| PRM Solutions, Inc. | — | Other | Series B | $24.0M | $308.9M | 2021 |
| Impliant Inc | — | Biotechnology | Series A | $15.6M | $240.5M | 2009 |
| Ampla Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $5.4M | $138.9M | 2010 |
| Exelixis Inc | — | Biotechnology | Seed | $3.0M | $134.3M | 2009 |
| Pop-Up Post Inc | — | Other | Pre-Seed | $878K | $8.1M | 2018 |
Charles Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Cohen | 1 | 38 |
| Peter Barrett | 1 | 18 |
| Frank McCormick | 1 | 7 |
| Eric Bednarski | 1 | 7 |
| BARRY BUTLER | 1 | 6 |
| Anthony Maida | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| Jason Fisherman | 1 | 5 |
| Todd Creech | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| Stelios Papadopoulos | 1 | 4 |
| Niki Pezeshki | 1 | 3 |
| Dalia Megiddo | 1 | 3 |
| BRIAN CAMERON | 1 | 2 |
| Thomas Riedhammer | 1 | 2 |
| George A. Scangos | 1 | 2 |
| Zvika Slovin | 1 | 2 |
| Susan Benton | 1 | 2 |
| Benjamin Cohen | 1 | 2 |
| James Butler | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.